152 related articles for article (PubMed ID: 34860497)
21. A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders.
Yang K; Zhao Y; Nie X; Wu H; Wang B; Almodovar-Rivera CM; Xie H; Tang W
Cell Chem Biol; 2020 Jul; 27(7):866-876.e8. PubMed ID: 32413286
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
[TBL] [Abstract][Full Text] [Related]
23. High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma.
Liu JR; Yu CW; Hung PY; Hsin LW; Chern JW
Biochem Pharmacol; 2019 May; 163():458-471. PubMed ID: 30885763
[TBL] [Abstract][Full Text] [Related]
24. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
25. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
[TBL] [Abstract][Full Text] [Related]
26. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice.
Huang M; Wang Q; Long F; Di Y; Wang J; Zhun Zhu Y; Liu X
FASEB J; 2020 Mar; 34(3):4107-4119. PubMed ID: 31971317
[TBL] [Abstract][Full Text] [Related]
27. Developing potent PROTACs tools for selective degradation of HDAC6 protein.
An Z; Lv W; Su S; Wu W; Rao Y
Protein Cell; 2019 Aug; 10(8):606-609. PubMed ID: 30603959
[No Abstract] [Full Text] [Related]
28. Acetylase inhibitor SI-2 is a potent anti-inflammatory agent by inhibiting NLRP3 inflammasome activation.
Liu L; Xu X; Zhang N; Zhang Y; Zhao K
Int Immunopharmacol; 2020 Oct; 87():106829. PubMed ID: 32736194
[TBL] [Abstract][Full Text] [Related]
29. Degradation of histone deacetylase 6 alleviates ROS-mediated apoptosis in renal ischemia-reperfusion injury.
Xia K; Qiu T; Jian Y; Liu H; Chen H; Liu X; Chen Z; Wang L
Biomed Pharmacother; 2023 Sep; 165():115128. PubMed ID: 37429230
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
Anh DT; Hai PT; Dung DTM; Dung PTP; Huong LT; Park EJ; Jun HW; Kang JS; Kwon JH; Tung TT; Han SB; Nam NH
Bioorg Med Chem Lett; 2020 Nov; 30(22):127537. PubMed ID: 32916298
[TBL] [Abstract][Full Text] [Related]
31. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
Front Immunol; 2021; 12():741839. PubMed ID: 34512673
[TBL] [Abstract][Full Text] [Related]
32. Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS.
Clénet ML; Keaney J; Gillet G; Valadas JS; Langlois J; Cardenas A; Gasser J; Kadiu I
Front Immunol; 2023; 14():1190219. PubMed ID: 37575265
[TBL] [Abstract][Full Text] [Related]
33. A highly HDAC6-selective inhibitor acts as a fluorescent probe.
Ho YH; Wang KJ; Hung PY; Cheng YS; Liu JR; Fung ST; Liang PH; Chern JW; Yu CW
Org Biomol Chem; 2018 Oct; 16(42):7820-7832. PubMed ID: 30168823
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts.
Park S; Shin J; Bae J; Han D; Park SR; Shin J; Lee SK; Park HW
Cells; 2020 Mar; 9(3):. PubMed ID: 32188057
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
36. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
37. Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation.
Wan P; Zhang Q; Liu W; Jia Y; Ai S; Wang T; Wang W; Pan P; Yang G; Xiang Q; Huang S; Yang Q; Zhang W; Liu F; Tan Q; Zhang W; Wu K; Liu Y; Wu J
FASEB J; 2019 Apr; 33(4):5793-5807. PubMed ID: 30653357
[TBL] [Abstract][Full Text] [Related]
38. Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.
Lawana V; Singh N; Sarkar S; Charli A; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
J Neuroimmune Pharmacol; 2017 Dec; 12(4):624-660. PubMed ID: 28466394
[TBL] [Abstract][Full Text] [Related]
39. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR
Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474
[TBL] [Abstract][Full Text] [Related]
40. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
